EGFR and non-small cell lung carcinoma: Local treatment (LT), such as surgery, RT or thermal ablation, of primary or metastatic lesions in oligometastatic or oligoprogressive disease has been shown to obtain clinical benefits in EGFR mutated-NSCLC [12, 13].